Your browser doesn't support javascript.
loading
Miltefosine as a PPM1A activator improves AD-like pathology in mice by alleviating tauopathy via microglia/neurons crosstalk.
Lv, Jianlu; Shen, Xingyi; Shen, Xinya; Li, Xiaoqian; Jin, Zhuoying; Ouyang, Xingnan; Lu, Jian; Zhu, Danyang; Wang, Jiaying; Shen, Xu.
  • Lv J; Jiangsu Key Laboratory of Drug Target and Drug for Degenerative Diseases, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Shen X; College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Shen X; Jiangsu Key Laboratory of Drug Target and Drug for Degenerative Diseases, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Li X; Jiangsu Key Laboratory of Drug Target and Drug for Degenerative Diseases, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Jin Z; Jiangsu Key Laboratory of Drug Target and Drug for Degenerative Diseases, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Ouyang X; Jiangsu Key Laboratory of Drug Target and Drug for Degenerative Diseases, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Lu J; Jiangsu Key Laboratory of Drug Target and Drug for Degenerative Diseases, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Zhu D; Jiangsu Key Laboratory of Drug Target and Drug for Degenerative Diseases, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Wang J; Jiangsu Key Laboratory of Drug Target and Drug for Degenerative Diseases, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Shen X; Jiangsu Key Laboratory of Drug Target and Drug for Degenerative Diseases, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Brain Behav Immun Health ; 26: 100546, 2022 Dec.
Article en En | MEDLINE | ID: mdl-36388134